Royal Bank of Canada set a $141.00 price target on athenahealth (NASDAQ:ATHN) in a research report report published on Thursday. The brokerage currently has a hold rating on the health services provider’s stock.
Several other research analysts have also weighed in on ATHN. SunTrust Banks increased their target price on shares of athenahealth to $180.00 and gave the stock a buy rating in a research note on Monday, February 5th. Canaccord Genuity increased their target price on shares of athenahealth from $123.00 to $137.00 and gave the stock a hold rating in a research note on Thursday, February 1st. ValuEngine lowered shares of athenahealth from a hold rating to a sell rating in a research note on Friday, February 2nd. BidaskClub lowered shares of athenahealth from a sell rating to a strong sell rating in a research note on Saturday, February 3rd. Finally, Oppenheimer reaffirmed a buy rating and set a $184.00 target price on shares of athenahealth in a research note on Friday, October 20th. Three investment analysts have rated the stock with a sell rating, sixteen have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average price target of $144.23.
Shares of athenahealth (ATHN) traded up $3.50 during mid-day trading on Thursday, reaching $141.24. 768,800 shares of the company’s stock traded hands, compared to its average volume of 570,839. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $5,650.00, a price-to-earnings ratio of 108.65, a PEG ratio of 2.91 and a beta of 1.35. athenahealth has a one year low of $95.01 and a one year high of $158.66.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.48. The company had revenue of $329.20 million during the quarter, compared to analyst estimates of $319.64 million. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. athenahealth’s revenue was up 14.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.62 earnings per share. sell-side analysts anticipate that athenahealth will post 2.29 EPS for the current fiscal year.
In related news, CEO Jonathan Bush sold 30,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 26th. The shares were sold at an average price of $134.80, for a total value of $4,044,000.00. Following the sale, the chief executive officer now owns 320,807 shares of the company’s stock, valued at $43,244,783.60. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $130.00, for a total transaction of $104,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 98,703 shares of company stock worth $13,487,150. 3.20% of the stock is owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in the business. LPL Financial LLC acquired a new stake in athenahealth during the fourth quarter worth approximately $207,000. Meadow Creek Investment Management LLC acquired a new stake in athenahealth during the fourth quarter worth approximately $132,000. Teachers Advisors LLC raised its holdings in athenahealth by 1.3% during the fourth quarter. Teachers Advisors LLC now owns 76,554 shares of the health services provider’s stock worth $10,185,000 after purchasing an additional 1,002 shares in the last quarter. Paloma Partners Management Co raised its holdings in athenahealth by 31.0% during the fourth quarter. Paloma Partners Management Co now owns 8,957 shares of the health services provider’s stock worth $1,191,000 after purchasing an additional 2,118 shares in the last quarter. Finally, Two Sigma Advisers LP acquired a new stake in athenahealth during the fourth quarter worth approximately $2,587,000.
ILLEGAL ACTIVITY NOTICE: This piece of content was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/16/athenahealth-athn-given-a-141-00-price-target-by-royal-bank-of-canada-analysts.html.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.